DUBLIN, December 23, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/x7lkkh/pain_management) has announced the addition of the "2013 Report on the International Pain Management Therapeutics Market - Includes Forecast to 2018" report to their offering.
The various pain management indications studied in this report include neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain and cancer pain. Market sizes and forecasts for the period 2010 - 2018 have been provided for each of the segments and sub-segments in terms of USD million, considering 2011 as the base year. The % compound annual growth rate (CAGR) for each market segment for the forecast period (2012 to 2018) has been provided along with market size estimations.
Geographically, the market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section of the report provides a detailed breakdown of various aspects of market dynamics such as drivers, restraints and opportunities along with market attractiveness analysis and Porter's five force analysis for the pain management therapeutics market.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Pain Management Therapeutics Market, by Therapeutic Class
4.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
4.6 Anti-Migraine Agents
4.7 Other Non-Narcotic Analgesics (Acetaminophen)
5 Global Pain Management Therapeutics Market, by Indication
5.1 Neuropathic Pain
5.3 Arthritic Pain
5.4 Chronic Back Pain
5.6 Post-operative pain
5.7 Cancer Pain
6 Global Pain Management Therapeutics Market, by Geography
7 Competitive Landscape
9 Company Profiles
For more information visit http://www.researchandmarkets.com/research/x7lkkh/pain_management
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved